Print

Elan Corporation PLC (ELN)'s Tysabri May Reverse MS Damage, Shares Up  
4/29/2009 7:28:54 AM

Bookmark and Share

Reuters -- Elan's Tysabri drug may be able to reverse damage caused by multiple sclerosis, the Irish drugmaker and its U.S. partner Biogen Idec said on Wednesday, boosting Elan's shares 10 percent.

//-->